BlackRock’s Pfizer PFE Stock Holding History

BlackRock’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,244,500	Closed	-$64.6M	–	5363
2023 Q4	$64.6M	Hold	2,244,500	–	–	﹤0.01%	2321
2023 Q3	$74.5M	Sell	2,244,500 -1,842,500	-45%	-$65.2M	﹤0.01%	2162
2023 Q2	$150M	Buy	+4,087,000	New	+$159M	﹤0.01%	1788
2022 Q2	–	Sell	-602,800	Closed	-$31.2M	–	5951
2022 Q1	$31.2M	Buy	+602,800	New	+$31.3M	﹤0.01%	2887
2019 Q3	–	Sell	-2,845,589	Closed	-$117M	–	5051
2019 Q2	$117M	Buy	+2,845,589	New	+$113M	0.01%	1801

Other funds holding PFE

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock's PFE Position: Q1 2026 in Review

BlackRock increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $138M and bringing the position to 498,257,550 shares worth $14B. The position accounts for 0.24% of the portfolio, ranked #63.

BlackRock first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.2B in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

BlackRock held 498,257,550 shares of Pfizer worth $14B as of Q1 2026.
BlackRock bought 5,195,022 Pfizer shares in Q1 2026, an estimated $138M.
Pfizer made up 0.24% of BlackRock's portfolio in Q1 2026, its #63 holding.
BlackRock first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
BlackRock's Pfizer position peaked at $24.2B in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.